Pharma stocks drop 10% by Q4 2026 on Trump drug price policies

Market overview

Trump's 2026 drug price reduction plan will face strong opposition from pharmaceutical lobbyists, leading to regulatory uncertainty. Market sentiment will turn negative as investors price in lower revenue projections for major drugmakers like Pfizer and Merck.

price prediction market

Implied probability (Yes)

72%

Source: user-generated

More price markets

• Bitcoin price exceeds $150,000 by end of 2026 — 68% Yes
• Bitcoin price recovers to $50,000 by December 2026 — 62% Yes
• Bitcoin price exceeds $100,000 within 6 months of Clarity Act passage — 70% Yes
• Coinbase stock to rise 15% by June 2026 amid crypto regulation clarity — 72% Yes
• NY crypto tax revenue will exceed $200M in 2027 — 65% Yes
• Will stock drop >15% on next financing terms? — 45% Yes
• Will enGene raise additional equity financing before Q1 2027? — 80% Yes
• Trading volume on Kalshi’s crypto futures exceeds $500M in first month — 60% Yes

Browse all price markets →